Trial Details

Not Recruiting
Basic Information
Clinical ID c5437
Identifier ACTRN12622000934741
Trial Title Tissue concentrations of thioguanine in rectal tissue samples in patients administered thioguanine rectally
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Oral and gastrointestinal; Oral and gastrointestinal;Oral and Gastrointestinal - Inflammatory bowel disease
Interventions Participants will self administer a rectal enema preparation of Pentasa enema 500mg combined with thioguanine 20mg daily for 7 days. This will be followed by a single 5-hour visit to the study clinic during which participants will have a flexible sigmoido
Participant Information
Sponsor Douglas Pharmaceuticals Ltd
City NULL
Country/Region New Zealand
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase EARLY_PHASE1
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL